申请人:——
公开号:US20040180940A1
公开(公告)日:2004-09-16
Novel thyroid receptor ligands are provided having the general formula I
1
wherein
X, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
, R
9
, R
10
, R
11
, R
12
and R
13
are as defined herein.
In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or which are dependent upon the expression of a T
3
regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.
提供一般式为I1的新型甲状腺受体配体,其中X、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12和R13如此定义。此外,还提供了一种方法,用于预防、抑制或治疗与代谢功能障碍相关或取决于T3调控基因表达的疾病或疾病,其中上述化合物以治疗有效量的方式给予。